Power Law company profile

Innocare

Biotech & Life Sciences · Haidian, China · Founded 2015 · IPO 2020 Unicorn

A Chinese biopharmaceutical company that develops treatment for cancer and autoimmune diseases

Valuation

$2.65B

Market cap · May/2026

Revenue

$139M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

5 investors on Innocare's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 5 investors entered at this stage

Jianxin Capital

Hillhouse Capital

Loyal Valley Capital

Vivo Capital

CCB International

Global footprint

Where Innocare has talent and traffic

Workforce by country

6 countries with
team presence

🇨🇳 China79.1%

🇺🇸 United States16.4%

🇩🇪 Germany1.3%

🇮🇹 Italy1.3%

🇭🇰 Hong Kong1.3%

Top 5 of 6 shown

Web traffic by country

3K monthly visits
across markets

🇺🇸 United States63.3%

🇮🇳 India23.3%

🇨🇦 Canada16.7%

Top 3 markets shown

Patent intelligence

$56M patent portfolio · 50 active families

Estimated portfolio value

$56M

2.1% of market cap · comparable to top peer Ascentage Pharma ($66M)

50 active patent families

Where Innocare innovates CarcinosisHeterocyclic compoundAutoimmune diseaseTyrosineMedicinal chemistry

Where Innocare concentrates vs peers

Each axis is a top-10 topic across Innocare and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Innocare

An AI-synthesized read of the highest-engagement posts about Innocare on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Innocare on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles